Immunogenicity of umbilical cord tissue-derived cells

Blood

Volumn 111, Issue 1, 2008, Pages 430-438

  Cho, Patricia S ^a   Messina, Darin J ^b   Hirsh, Erica L ^a   Chi, Nina ^b   Goldman, Stephanie N ^b   Lo, Diana P ^a   Harris, Ian R ^b   Popma, Sicco H ^b   Sachs, David H ^a   Huang, Christene A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL THERAPY; CELL TYPE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; SWINE; TISSUE REPAIR; UMBILICAL CORD; UMBILICAL CORD TISSUE DERIVED CELL;

EID: 38049181475     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-03-078774     Document Type: Article

References (31)

1. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004;36:568-584.
2. Reyes M, Lund T, Lenvik T, et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001;98:2615-2625.
3. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev. 2005;85:1373-1416.
4. Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells. 2004;22:1330-1337.
5. Jiang Y, Vaessen B, Lenvik T, et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol. 2002;30:896-904.
6. Panepucci RA, Siufi JL, Silva WA Jr, et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells. 2004;22:1263-1278.
7. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-49.
8. Zimmet JM, Hare JM. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res Cardiol. 2005;100:471-481.
9. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309-313.
10. Koc ON, Day J, Nieder M, et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002;30:215-222.
11. Weiss ML, Mitchell KE, Hix JE, et al. Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp Neurol. 2003;182:288-299.
12. Odeberg J, Piao JH, Samuelsson EB, Falci S, Akesson E. Low immunogenicity of in vitro-expanded human neural cells despite high MHC expression. J Neuroimmunol. 2005;161:1-11.
13. Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res. 2005;305:33-41.
14. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31:890-896.
15. Poncelet AJ, Vercruysse J, Saliez A, Gianello P. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation. 2007;83:783-790.
16. Lund RD, Wang S, Lu B, et al. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells. 2007;25:602-611.
17. Sachs DH, Leight G, Cone J, et al. Transplantation in miniature swine, I: fixation of the major histocompatibility complex. Transplantation. 1976;22:559-567.
18. Sachs DH. MHC homozygous miniature swine. In: Swindle MM, Moody DC, Phillips LD, eds. Swine as Models in Biomedical Research. Ames, IA: Iowa State University Press; 1992:3-15.
19. Mezrich JD, Haller GW, Arn JS, et al. Histocompatible miniature swine: an inbred large-animal model. Transplantation. 2003;75:904-907.
20. Horner BM, Cina RA, Wikiel KJ, et al. Predictors of organ allograft tolerance following hematopoietic cell transplantation. Am J Transplant. 2006;6:2894-2902.
21. Cina RA, Wikiel KJ, Lee PW, et al. Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation. Transplantation. 2006;81:1677-1685.
22. Nobori S, Samelson-Jones E, Shimizu A, et al. Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine. Transplantation. 2006;81:26-35.
23. Gianello PR, Sachs DH. Effect of major histocompatibility complex matching on the development of tolerance to primarily vascularized renal allografts: a study in miniature swine. Hum Immunol. 1996;50:1-10.
24. Pescovitz MD, Thistlethwaite JR Jr, Auchincloss H Jr, et al. Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med. 1984;160:1495-1508.
25. Kirkman RL, Colvin MW, Flye GS, et al. Transplantation in miniature swine, VI: factors influencing survival of renal allografts. Transplantation. 1979;28:18-23.
26. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 1985. NIH publication no. 86-23.
27. Schnitzlein WM, Zuckermann FA. Determination of the specificity of CD45 and CD45R monoclonal antibodies through the use of transfected hamster cells producing individual porcine CD45 isoforms. Vet Immunol Immunopathol. 1998;60:389-401.
28. Popma SH, Krasinskas AM, McLean AD, et al. Immune monitoring in xenotransplantation: the multiparameter flow cytometric mixed lymphocyte culture assay. Cytometry. 2000;42:277-283.
29. Jordan HE. The histology of the umbilical cord of the pig, with special reference to the vasculogenic and hematopoietic activity of its extensively vascularized connective tissue. Am J Anat. 1919;26:1-28.
30. Mathes DW, Yamada K, Randolph MA, et al. In utero induction of transplantation tolerance. Transplant Proc. 2001;33:98-100.
31. Haller GW, Lima B, Kunisaki SM, et al. MHC alloantigens elicit secondary, but not primary, indirect in vitro proliferative responses. J Immunol. 2002;169:3613-3621.